Category Archives: Cardiovascular

Blood tests in barber shops and supermarkets to tackle heart disease

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email The NHS is expanding blood pressure checks available in local communities as part of a major drive to prevent strokes and heart attacks. NHS figures show high street pharmacies delivered a total […]

Test your knowledge on pregnancy 1: effects on haematological and cardiovascular systems

Test your knowledge and gain evidence of your professional development with Nursing Times Self-assessment bite-sized CPD This self-assessment tests your knowledge after reading the following article: Knight J (2023) Pregnancy 1: effects on haematological and cardiovascular systems. Nursing Times; 119: 9 Nursing Times Self-assessment enables you to test your knowledge after reading a Nursing Times […]

Evangelical Community Hospital’s cardiovascular and pulmonary rehabilitation programs certified by industry leader

#inform-video-player-1 .inform-embed { margin-top: 10px; margin-bottom: 20px; } #inform-video-player-2 .inform-embed { margin-top: 10px; margin-bottom: 20px; } LEWISBURG — Evangelical Community Hospital announces the re-certification of its cardiovascular and pulmonary rehabilitation programs by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). This certification is recognition of Evangelical’s commitment to improving the quality of life of […]

Cardiovascular prognosis of subclinical COPD

Eduardo José Pereira Ferreira,1– 4 Lucas Villar Shan de Carvalho Cardoso,3,5 Carlos José Oliveira de Matos,6 Igor Larchert Mota,3,4 Juliana Maria Chianca Lira,3,5 Mayara Evelyn Gomes Lopes,3,5 Giulia Vieira Santos,3,5 Maria Luiza Dória Almeida,2,3,5 Manuel Herminio Aguiar-Oliveira,2,3,5 Antônio Carlos Sobral Sousa,2– 5 Enaldo Vieira de Melo,3,5 Joselina Luzia Menezes Oliveira2– 5 1Department of Medicine, Federal […]

Study highlights the economic burden of cardiovascular diseases in the European Union

Cardiovascular disease (CVD) cost the EU an estimated €282 billion in 2021, according to late breaking research presented at ESC Congress 2023. Health and long-term care accounted for €155 billion (55%) of these costs, equalling 11% of EU health expenditure. The analysis was a collaborative effort by the European Society of Cardiology (ESC) and the […]

Early elevation of high-sensitivity C-reactive protein as a predictor for cardiovascular disease incidence and all-cause mortality: a landmark analysis

Abstract We investigated the association between early elevation of high-sensitivity C-reactive protein (hsCRP) and cardiovascular disease (CVD) incidence, all-cause mortality, and CVD mortality. We analyzed 6567 participants from the Korean Genome and Epidemiology Study_Ansan_Ansung cohort between 2005 and 2018. The Kaplan–Meier curves and modified Cox regression by Fine and Gray were used to estimate hazard […]

With a heavy heart: Cardiovascular disease is costing the EU 11% of its overall health budget

29 Aug 2023 — The European Society of Cardiology (ESC), in collaboration with the University of Oxford, has presented staggering figures about the cost of cardiovascular diseases on European health care expenses, estimated at €282 billion (US$305 billion) from data collected and processed in 2021. The cost of general health care and long-term care alone […]

Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis

Search databases Cochrane central, MEDLINE (Subset PubMed), EMBASE, Web of Science, http://www.ClinicalTrials.gov and Google scholar were searched for relevant publications involving BP-DES in patients with DM versus non-DM. Search strategies The above mentioned databases were searched for relevant publications using the following search terms: ‘biodegradable polymer drug eluting stents and diabetes mellitus’, ‘biodegradable polymer DES […]

Apolipoprotein B in cardiovascular risk assessment

Apolipoprotein (apo) B measurement is a recommended alternative to low-density lipoprotein cholesterol (LDL-C) The 2021 Canadian Cardiovascular Society guideline on dyslipidemia recommends that physicians may use levels of either non-high-density lipoprotein cholesterol (HDL-C) or apo B instead of LDL-C for screening and targets of treatment.1 Non-HDL-C represents total cholesterol minus cholesterol from HDL particles; apo […]